Building Trust to Minimize Harm

Your regulatory partners in bringing better nicotine and cannabis products to market.

Tobacco molecule Tobacco leaves and molecule


In an evolving regulatory environment, where the laws can be unclear, you need an agile partner to stay abreast of changing policy and tell you what you need to hear in order to remain compliant.


Are you ready for the regulatory wave? Self regulation, by understanding the science behind your product and the impact of your marketing, is the best offense and critical in helping to shape this emerging industry.

Marijuana molecule Marijuana leaf and molecule

Navigating rapid industry shifts requires trustworthy advisors
who have YOUR best interests in mind.

Our Process

Regulatory compliance is a marathon. We arm businesses with the tools to stay in the race.


We’ll look at your design, manufacturing and marketing approach with a regulatory lens to identify strengths and opportunities.


Compliance doesn’t always mean starting from scratch. Leverage our team’s industry knowledge to build a regulatory roadmap.


Understanding your product on a cellular level is the key to harm reduction. Our team goes beyond the data, helping you make sense of those insights.


Successful PMTA submissions don’t just spout facts. The FDA needs a compelling narrative that demonstrates your product is suitable for safeguarding public health. We help you tell your story and champion your product to market.


Whether its post-submission or post-authorization, we’ll help you maintain compliance through the life of your product.

%quote% %author%; %title%

Our Insights

  • Cannabis Science Conference Logo

    2 min. read

    2024 Cannabis Science Conference Recap

    We recently had the pleasure of participating in the Cannabis Science Conference 2024, a premier event that brought together industry leaders, scientists, and regulatory experts to share their insights and advancements in the field. Our social media coverage highlighted several key moments from the conference, showcasing the breadth of knowledge and innovation present. Read More

  • CannMed Group Image

    2 min. read

    CannMed24 Conference Recap: Pioneering the Future of Cannabis in Biopharma

    The CannMed24 conference, held from May 12-15, was a valuable event for professionals in the cannabis and biopharma industries. This year’s gathering highlighted the burgeoning partnership between biopharma companies and the cannabis sector, driven by both anecdotal evidence of cannabis’ benefits and an increasing demand for scientifically rigorous research and development. Read More

  • 3 min. read

    Quitting Camel Country

    Here’s what Cheryl Olson says she learned while writing her latest Tobacco Reporter article, about smoking and harm reduction in Middle East nations.  Read More

Back to top